Evolutionary Therapy for Rhabdomyosarcoma

NCT04388839 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Rhabdomyosarcoma

Interventions

DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Vinorelbine
DRUG: Actinomycin D
DRUG: Cyclophosphamide Pill

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]